Clinical Trial

A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the relative effectiveness, safety, and durability of the most commonly used prescription (zolpidem, trazodone) and over-the-counter (OTC) (melatonin, diphenhydramine) medications for insomnia, as well as a less commonly used prescription that may have a better risk/benefit profile (doxepin).
Protocol Amendment History 2 changes
critical Recruitment opened 2026-06-06
critical Primary endpoint(s) modified 2026-05-09
Trial Details
NCT Number NCT07542756
Lead Sponsor University of Pennsylvania
Collaborators: Patient-Centered Outcomes Research Institute
Conditions Insomnia, Insomnia Disorder, Chronic Insomnia, Chronic Insomnia Disorder
Enrollment 1,200 participants
Start Date 2026-05-01
Primary Completion 2032-01-01 (estimated)
Study Completion 2032-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-05